Author

D. S. Wijesinghe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Assay:metabolomics· 2 Approach:statistical model· 2 Approach:experimental assay· 1

Frequent Co-Authors

D. Contaifer· 3 shared N. G. Kumar· 2 shared A. A. Toor· 1 shared A. P. Rossi· 1 shared B. Broering· 1 shared B. J. Fisher· 1 shared C. Chou· 1 shared C. H. Roberts· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

D. Contaifer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistrybioRxivPreprintJun 21, 2022

A Pre-transplant Blood-based Lipid Signature for Prediction of Antibody-mediated Rejection in Kidney Transplant Patients

M. A. Alsultan, G. Gupta, S. Bobba…·D. S. Wijesinghe

This study identifies a lipid-based biomarker panel that predicts antibody-mediated rejection in kidney transplant patients with high accuracy.

DOI 10.1101/460030

humanmetabolomics

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivMay 27, 2019

Detecting Direct Oral Anticoagulants in Trauma Patients using Liquid Chromatography-Mass Spectrometry: a Novel Approach to Medication Reconciliation

S. Jayaraman, J. H. DeAntonio, S. W. Leichtle…·D. S. Wijesinghe

This paper develops an LCMS-based assay to detect DOACs in trauma patients, achieving high accuracy and identifying potential medication reconciliation issues.

DOI 10.1097/ta.0000000000002527

humanexperimental assay

𝕏 PostBluesky

BiochemistrybioRxivNov 20, 2018

Risk stratification of allogeneic stem cell recipients with respect to the potential for development of GVHD via their pre-transplant plasma lipid and metabolic signature

D. Contaifer, C. H. Roberts, N. G. Kumar…·D. S. Wijesinghe

This study identifies pre-transplant plasma lipid and metabolic biomarkers that predict graft vs. host disease (GVHD) risk in allogeneic stem cell transplant recipients with high accuracy.

DOI 10.3390/cancers11081051

humanmetabolomics

𝕏 PostBluesky